| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.27 | 0.1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.064 | 0.1 |